Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone with Viscosupplementation for Knee Osteoarthritis
NCT01335321Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Mar 2011
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of triamcinolone hexacetonide in osteoarthritis (OA) (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index at 4 weeks, Lequesne Algofunctional Index at 4 weeks and 1 more. Started Mar 2011; status: completed.
02
Drugs
triamcinolone hexacetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01335321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01335321.